Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease

Clinical trial NCT06381518 · COMPLETED

Trial details

NCT number: NCT06381518
Sponsor: Zuyderland Medisch Centrum
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

IBD Infliximab Crohn Disease Ulcerative Colitis

Start date: 2024-03-12
Primary completion: 2025-10-10
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.